SCHEMBL20174712

SCHEMBL20174712

c1ccc(-c2cc(-c3ccccc3-c3ccc4c(c3)-c3oc5ccccc5c3C43c4ccccc4-c4ccccc43)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.36
MAPT P10636 9/20 0.36
MEN1 O00255 7/20 0.36
ALDH1A1 P00352 6/20 0.36
HPGD P15428 6/20 0.36
NTSR1 P30989 1/20 0.36
LMNA P02545 4/20 0.35
KDM4E B2RXH2 4/20 0.35
GLA P06280 1/20 0.35
MAOB P27338 5/20 0.33
MAOA P21397 3/20 0.33
TSHR P16473 2/20 0.32
POLB P06746 1/20 0.32
HTT P42858 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
CYP2C19 P33261 3/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
NPSR1 Q6W5P4 2/20 0.31
CYP1A2 P05177 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174217 0.94 KMT2A (0.37) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL20174223 0.94 KMT2A (0.37) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL20174248 0.93 KMT2A (0.35) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL22326524 0.93 KMT2A (0.36) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL20174245 0.92 KMT2A (0.38) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL20174240 0.91 KMT2A (0.41) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL20174259 0.88 CYP1A1 (0.39) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL20174239 0.88 KMT2A (0.33) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL20174254 0.88 CYP1A1 (0.39) KMT2AMAPTMEN1ALDH1A1HPGD
SCHEMBL20174221 0.88 ALDH1A1 (0.36) KMT2AMAPTMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG KMT2A 1480/4885MAPT 811/4885MEN1 611/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG KMT2A 1480/4885MAPT 811/4885MEN1 611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.